Interagency Patent Coordination and Improvement Act of 2022

United States117th CongressS-4430Senate
Updated: Aug 2, 2022

Summary

Interagency Patent Coordination and Improvement Act of 2022 This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (PTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products. The task force's duties shall include establishing a process for the PTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties.

Bill texts

Available versions
View official text

2 versions available

All available records shown.

Timeline

  1. Read twice and referred to the Committee on the Judiciary.

    Senate

  2. Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.

    Senate

  3. Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.

    Senate

  4. Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.

    Senate